LOW-VOLUME · SEX-BALANCED

guanfacine Side Effects

guanfacine (also sold as Intuniv, Tenex) is a LOW-VOLUME FAERS extract #355 of 524 by FAERS report count. Still opens on SEX-BALANCED: 37% of sex-coded reports are female (2,210 F / 3,811 M).

Data updated 2026-05-15

7,386
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

guanfacine reporting skew - 37% of sex-coded reports are female (2,210 F / 3,811 M). Volume band LOW-VOLUME #355 of 524 by FAERS report count; caseload WATCHLIST.

Thinner FAERS extract for guanfacine (Intuniv) (7,386 reports #355 of 524 by FAERS report count). 37% of sex-coded reports are female (2,210 F / 3,811 M). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.

SOMNOLENCE leads 455 of 7,386 reports

SOMNOLENCE
455
AGGRESSION
376
FATIGUE
329
HYPOTENSION
289
DIZZINESS
270
HEADACHE
268
INSOMNIA
264
SUICIDAL IDEATION
259
ANXIETY
250
BRADYCARDIA
249
NAUSEA
245
ABNORMAL BEHAVIOUR
215
TOXICITY TO VARIOUS AGENTS
213
INTENTIONAL OVERDOSE
212
ELECTROCARDIOGRAM QT PROLONGED
211
PRODUCT QUALITY ISSUE
206
VOMITING
201

Who reports · age peak 0-17 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 2,210 (36%)
Male 3,811 (62%)
Unknown 102

Age peak 0-17 (3,034 reports)

0-17 3,034 (68%)
18-44 884 (20%)
45-64 338 (8%)
65-74 90 (2%)
75+ 89 (2%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death appears on 228 reports (3.1% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
COMPLETED SUICIDE 68
DEATH 51
TOXICITY TO VARIOUS AGENTS 31
HYPOTENSION 16
COMA 13
GASTROINTESTINAL HAEMORRHAGE 13
TACHYCARDIA 13
RESPIRATORY DEPRESSION 12
DEPRESSED LEVEL OF CONSCIOUSNESS 11
ELECTROCARDIOGRAM QT PROLONGED 11
AGITATION 10
CARDIAC ARREST 10
DELIRIUM 10
DRUG INTERACTION 10
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 10
OVERDOSE 10
PARAESTHESIA 10
SUSPECTED SUICIDE 10
ASTHENIA 9

Reactions in Hospitalization Reports

Hospitalization mid-share (1,757, 23.8%). Co-reported reactions:

Reaction Reports
INTENTIONAL OVERDOSE 181
BRADYCARDIA 175
TOXICITY TO VARIOUS AGENTS 169
HYPOTENSION 164
SOMNOLENCE 123
OVERDOSE 106
DRUG INTERACTION 99
VOMITING 92
SUICIDE ATTEMPT 89
AGGRESSION 84
AGITATION 83
DIZZINESS 78
NAUSEA 73
ELECTROCARDIOGRAM QT PROLONGED 72
HYPERTENSION 72
SINUS BRADYCARDIA 64
CONDITION AGGRAVATED 62
HEADACHE 62
How to read guanfacine FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)

FAERS holds 7,386 voluntary reports linked to guanfacine (Intuniv, Tenex), 2004-2025. Death is listed on 228 (3.1%). Hospitalization appears on 1,757 (23.8%). Top co-reported indication: Attention Deficit/Hyperactivity Disorder.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with guanfacine

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.